Guggenheim Capital LLC Amgen Inc Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Guggenheim Capital LLC holds 246,694 shares of AMGN stock, worth $72.7 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

246,694

Previous 277,069 10.96%

Holding current value

$72.7 Million

Previous $86.6 Million 8.18%

% of portfolio

0.57%

Previous 0.62%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $9.4 Million - $10.2 Million	-30,375 Reduced 10.96%	246,694 $79.5 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $3.08 Million - $3.74 Million	-11,710 Reduced 4.06%	277,069 $86.6 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $1.03 Million - $1.25 Million	3,839 Added 1.35%	288,779 $82.1 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $3.66 Million - $4.13 Million	-14,304 Reduced 4.78%	284,940 $82.1 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $1.65 Million - $2.05 Million	7,542 Added 2.59%	299,244 $80.4 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $5.82 Million - $6.89 Million	27,176 Added 10.27%	291,702 $64.8 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $5.36 Million - $6.53 Million	23,745 Added 9.86%	264,526 $63.9 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $9.81 Million - $12.5 Million	-42,846 Reduced 15.11%	240,781 $63.2 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $87,090 - $98,222	388 Added 0.14%	283,627 $63.9 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $8.04 Million - $8.95 Million	-34,851 Reduced 10.96%	283,239 $68.9 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $9.07 Million - $10 Million	-41,356 Reduced 11.51%	318,090 $76.9 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $9.48 Million - $10.8 Million	47,642 Added 15.28%	359,446 $80.9 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $993,211 - $1.16 Million	4,679 Added 1.52%	311,804 $66.3 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $5.83 Million - $6.47 Million	24,963 Added 8.85%	307,125 $74.9 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $6.28 Million - $7.32 Million	-28,299 Reduced 9.12%	282,162 $70.2 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $5.06 Million - $6.02 Million	23,368 Added 8.14%	310,461 $71.4 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $6.31 Million - $7.01 Million	-26,880 Reduced 8.56%	287,093 $73 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $10.3 Million - $12.7 Million	52,267 Added 19.97%	313,973 $74.1 Million
Q1 2020 Jun 02, 2020	SELL	$182.24 - $241.7 $12.9 Million - $17.1 Million	-70,834 Reduced 21.3%	261,706 $53.1 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $5.71 Million - $7.33 Million	30,153 Added 9.97%	332,540 $80.2 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $73,474 - $88,037	-422 Reduced 0.14%	302,387 $58.5 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $1.89 Million - $2.21 Million	-11,312 Reduced 3.6%	302,809 $55.8 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $2.67 Million - $3.01 Million	14,785 Added 4.94%	314,121 $59.7 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $9.62 Million - $11.2 Million	-53,937 Reduced 15.27%	299,336 $58.3 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $5.68 Million - $6.41 Million	-30,674 Reduced 7.99%	353,273 $73.2 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $51.6 Million - $57.9 Million	-310,604 Reduced 44.72%	383,947 $70.9 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $6.73 Million - $7.86 Million	-39,715 Reduced 5.41%	694,551 $118 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $1.85 Million - $2.07 Million	10,980 Added 1.52%	734,266 $128 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $121 Million - $138 Million	723,286	723,286 $135 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Amgen Inc Transaction History